KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biolife Solutions (BLFS) Equity Income (2017 - 2019)

Biolife Solutions (BLFS) has disclosed Equity Income for 3 consecutive years, with -$291000.0 as the latest value for Q3 2019.

  • On a quarterly basis, Equity Income fell 576.74% to -$291000.0 in Q3 2019 year-over-year; TTM through Dec 2020 was -$291000.0, a 60.68% increase, with the full-year FY2019 number at -$739000.0, down 9.97% from a year prior.
  • Equity Income was -$291000.0 for Q3 2019 at Biolife Solutions, down from -$217000.0 in the prior quarter.
  • In the past five years, Equity Income ranged from a high of -$43000.0 in Q3 2018 to a low of -$309000.0 in Q4 2018.
  • A 3-year average of -$219818.2 and a median of -$229368.0 in 2017 define the central range for Equity Income.
  • Peak YoY movement for Equity Income: skyrocketed 80.25% in 2018, then plummeted 576.74% in 2019.
  • Biolife Solutions' Equity Income stood at -$297792.0 in 2017, then fell by 3.76% to -$309000.0 in 2018, then grew by 5.83% to -$291000.0 in 2019.
  • Per Business Quant, the three most recent readings for BLFS's Equity Income are -$291000.0 (Q3 2019), -$217000.0 (Q2 2019), and -$232000.0 (Q1 2019).